Sandra Costa (PhD) is Auxiliary Invited Researcher working at the Surgical Sciences Research Domain, at the Life and Health Sciences Research Institute (ICVS), University of Minho (Portugal).
She is graduated in Applied Biology by the University of Minho in 2000, completed a Master degree in Oncology by Instituto de Ciências Biomédicas Abel Salazar, University of Porto in 2003 and concluded a PhD degree in Health Sciences by Health Sciences School, University of Minho in 2007.
Her research goal is to unveil key players in lung development and injury, namely non-epithelial cells, granting us the possibility to manipulate them towards a desired phenotype and redirect the cellular mechanisms that favour lung repair, remodelling and regeneration, both in pre-and post-natal lung diseases.
She is dedicating her research to understand how tissue-resident macrophages orchestrate lung development. Furthermore, she is focused on unravel molecular signalling pathways underlying epithelial-endothelial crosstalk in lung morphogenesis, namely HGF/c-Met.
10 Selected Peer-reviewed Publications (selected from 35 peer-reviewed publications; H index - 21)
Hamm A, Veschini L, Takeda Y, Costa S, Delamarre E, Squadrito ML,Henze A-T, Wenes M, Serneels J, Pucci F, Roncal C, Anisimov A, Alitalo K,DePalma M, Mazzone M. PHD2 regulates arteriogenic macrophages through TIE2signaling. EMBO Mol Med (2013); 5(6): 843-57.
Tiburcio M, Costa S, Duarte MF, Schmitt FC, Longatto-Filho A. Characterization of PAR1 and FGFR1 expression in invasive breast carcinomas: Prognostic significance. Oncol Lett (2012); 4(4): 647-657.
Takeda Y, Costa S, Delamarre E, Roncal C, Leite De Oliveira R, Squadrito ML, Finisguerra V, Deschoemaeker S, Bruyère F, Wenes M, Hamm A, Serneels J, Magat J, Bhattacharyya T, Anisimov A, Jordan BF, Alitalo K, Maxwell P, Gallez B, Zhuang ZW, Saito Y, Simons M, De Palma M, Mazzone M. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature (2011); 479(7371): 122-126.
Costa BM, Viana-Pereira M, Fernandes R, Costa S, Linhares P, Vaz R, Pinheiro C, Lima J, Soares P, Silva A, Pardal F, Amorim J, Nabiço R, Almeida R, Alegria C, Pires MM, Pinheiro C, Carvalho E, Oliveira P, Lopes JM, Reis RM. Impact of EGFR genetic variants on glioma risk and patient outcome. Cancer Epidemiol Biomarkers Prev (2011); 20(12): 2610-2617.
Rolny C, Mazzone M, Tugues S, Laoui D, Johansson I, Coulon C, SquadritoML, Segura I, Li X, Knevels E, Costa S, Vinckier S, Dresselaer T, ÅkerudP, De Mol M, Phillipson M, Wyns S, Larsson E, Buysschaert I, Botling J,Himmelreich U, Van Ginderachter JO, De Palma M, Dewerchin M, Claesson-Welsh, Carmeliet P. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. CancerCell (2011); 19(1): 31-44.
Albergaria A, Paredes J, Sousa B, Milanezi F,Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, Lunet N,Schmitt F. Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Res (2009);11(3): R40.
Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R and Schmitt F. Importance ofTP53 codon 72 and intron 3 duplication16bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer (2008); 8:32.
Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R and Schmitt F. XRCC1 Arg399Gln and RAD51 5’UTR G135C polymorphisms and their outcome in tumor aggressiveness and survival of Portuguese breast cancer patients. Breast Cancer Res Treat(2008), 191(1):183-185.
Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R and Schmitt F. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer ResTreat (2007); 103 (2): 209-217.Costa S, Pinto D, Pereira D, Vasconcelos A, Afonso-Lopes C, Osório T, Lopes C, Medeiros R. Importance of Xeroderma Pigmentosum Group D Polymorphisms in Susceptibility to Ovarian Cancer. Cancer Letters (2007); 246 (1-2): 324-330.